Physician profile
John D Edwards
NPI 1336158294
$8,641.43
in general payments reported to CMS, 2019-2025
33 companies · $1,462 in 2025
The $1,462 reported for 2025 was more than what 86% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.45 · 2020: $214 · 2021: $1,646 · 2022: $1,789 · 2023: $2,352 · 2024: $1,116 · 2025: $1,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,928.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,631.81 | 2021-2025 | Inspire |
| Glaxosmithkline, LLC. | $760.21 | 2021-2025 | Nucala |
| Medtronic, INC. | $753.09 | 2021-2024 | Propel, Sinuva, Stealthstation S8 Platform |
| Genzyme Corporation | $600.11 | 2020-2024 | |
| Aerin Medical INC. | $572.79 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $439.09 | 2021-2025 | Cuvitru, Takhzyro |
| Optinose US, INC. | $434.54 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $415.87 | 2020-2025 | Dupixent |
| Grifols USA, LLC | $310.88 | 2020-2025 | Xembify |
| Ars Pharmaceuticals Operations, INC. | $188.32 | 2025 | Neffy |
| Itamar Medical INC | $184.20 | 2022-2023 | Watchpatone |
| Intersect Ent, INC. | $182.75 | 2020-2021 | |
| Acclarent, INC | $147.79 | 2021-2023 | Trudi Nav Cable |
| Hologic Sales and Service, LLC | $144.38 | 2025 | Coolseal Generator |
| Stryker Corporation | $107.17 | 2020-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $98.58 | 2021-2023 | Grastek, Odactra, Ragwitek |
| Csl Behring | $93.59 | 2020-2023 | Hizentra |
| Astrazeneca Pharmaceuticals Lp | $66.62 | 2020-2025 | Tezspire |
| Kaleo, INC. | $66.30 | 2021-2022 | |
| Amgen INC. | $55.63 | 2023-2024 | Tezspire |
| Blueprint Medicines Corporation | $46.81 | 2024-2025 | Ayvakit |
| Octapharma USA, INC. | $44.10 | 2021 | |
| Covidien Lp | $37.56 | 2019 | |
| Paratek Pharmaceuticals, INC. | $36.59 | 2025 | Xhance |
| Merck Sharp & Dohme LLC | $35.18 | 2021-2023 | |
| Hikma Pharmaceuticals USA | $34.59 | 2023 | Ryaltris |
| Phathom Pharmaceuticals, INC. | $27.49 | 2024-2025 | Voquezna |
| Novartis Pharmaceuticals Corporation | $26.62 | 2025 | |
| Ambu INC. | $26.01 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $24.89 | 2019 | |
| Aroa Biosurgery Incorporated | $24.57 | 2024 | |
| Checkpoint Surgical, INC | $11.79 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.